Verification of the expression trend and interaction prediction of innate immune cells and immune-checkpoint molecules in the process of oral mucosal carcinogenesis
View abstract on PubMed
Summary
This summary is machine-generated.This study reveals that specific innate immune cells influence oral cancer progression by modulating immune-checkpoint molecules like CTLA4 and PD-L1. Targeting these cells offers a potential immunotherapy strategy to suppress oral mucosal carcinogenesis.
Area Of Science
- Immunology
- Oncology
- Cancer Research
Background
- Oral mucosal carcinogenesis involves complex immune system interactions.
- Understanding the role of innate immune cells and immune-checkpoint molecules is crucial for developing effective cancer therapies.
Purpose Of The Study
- To investigate the expression trends of innate immune cells and immune-checkpoint molecules during oral mucosal carcinogenesis.
- To predict interactions between these components for potential immunotherapy strategies against oral cancer.
Main Methods
- Utilized The Cancer Genome Atlas (TCGA) database to analyze immune cell and immune-checkpoint molecule expression.
- Collected and analyzed clinical patient blood routine data for peripheral blood immune cell assessment.
- Performed immunohistochemical and special staining to identify and validate immune cells and molecules in various stages of oral carcinogenesis.
- Conducted survival analysis to correlate immune components with oral squamous cell carcinoma prognosis.
Main Results
- Monocytes and neutrophils expression increased, while mast cells decreased during oral carcinogenesis.
- Expression of immune-checkpoint molecules, cytotoxic T-lymphocyte-associated protein 4 (CTLA4) and programmed cell death-ligand (PD-L1), also increased.
- Monocytes, neutrophils, and eosinophils correlated positively with CTLA4 and PD-L1, potentially promoting tumor immune escape.
- Mast cells showed a negative correlation, suggesting a role in inhibiting immune escape.
Conclusions
- Specific innate immune cell modulation can regulate CTLA4 and/or PD-L1 expression.
- Interfering with these immune cells may inhibit tumor immune escape and delay oral mucosal carcinogenesis.
- This suggests a potential immunotherapy approach for oral cancer treatment.

